Evidence map›Paper›PMID 37584694›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2023

ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.

Hequn Li, Fazila Bunglawala, Nicola J Hewitt, Ruth Pendlington, Richard Cubberley, Beate Nicol, Sandrine Spriggs, Maria Baltazar, Sophie Cable, Matthew Dent

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hequn LiUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.ORCID 0000-0002-5529-9236
Fazila BunglawalaUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Nicola J HewittCosmetics Europe, Auderghem 1160, Belgium.
Ruth PendlingtonUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Richard CubberleyUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Beate NicolUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Sandrine SpriggsUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Maria BaltazarUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Sophie CableUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.
Matthew DentUnilever Safety and Environmental Assurance Centre, Sharnbrook MK44 1LQ, UK.

Funding

Cosmetics Europe Long Range Science Strategy
6 · The paper itself

Abstract

Estimating human exposure in the safety assessment of chemicals is crucial. Physiologically based kinetic (PBK) models which combine information on exposure, physiology, and chemical properties, describing the absorption, distribution, metabolism, and excretion (ADME) processes of a chemical, can be used to calculate internal exposure metrics such as maximum concentration and area under the concentration-time curve in plasma or tissues of a test chemical in next-generation risk assessment. This article demonstrates the development of PBK models for 3 UV filters, specifically octyl methoxycinnamate, octocrylene, and 4-methylbenzylidene camphor. The models were parameterized entirely based on data obtained from in vitro and/or in silico methods in a bottom-up modeling approach and then validated based on human dermal pharmacokinetic (PK) data. The 3 UV filters are "difficult to test" in in vitro test systems due to high lipophilicity, high binding affinity for proteins, and nonspecific binding, for example, toward plastic. This research work presents critical considerations in ADME data generation, interpretation, and parameterization to assure valid PBK model development to increase confidence in using PBK modeling to help make safety decisions in the absence of human PK data. The developed PBK models of the 3 chemicals successfully simulated the plasma concentration profiles of clinical PK data following dermal application, indicating the reliability of the ADME data generated and the parameters determined. The study also provides insights and lessons learned for characterizing ADME and developing PBK models for highly lipophilic and protein-bound chemicals in the future.

Indexed as

Models, BiologicalHumansIn Vitro TechniquesKineticsReproducibility of ResultsRisk AssessmentADMEdifficult-to-test chemicalsNAMsPBK modelingUV filters

Identifiers

PMID37584694
PMCPMC10613959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.